Product Overview
ToMorrow® gives dairy producers time-tested, broad-spectrum control against the harmful organisms that cause mastitis in dry cows.
ToMorrow® has been an effective extended therapy treatment for more than 25 years, and studies have shown no change in the development of bacterial resistance.1,2ToMorrow® has been shown by extensive clinical studies to be efficacious in the treatment mastitis in dry cows, when caused by Streptococcus agalactiae and Staphylococcus aureus, including penicillin-resistant strains.
